Brochure
10 Sep 2026
From Lab to Launch Your Partner At Every Step
PDF 4.0 MB
As a leading contract development and manufacturing organization (CDMO) with a singular focus on sterile injectables, Simtra BioPharma Solutions provides customized end-to-end services that meet the unique challenges of manufacturing injectables, from product development to clinical and commercial production at any scale.
Content provided by our supplier
Simtra BioPharma Solutions
-
Country/Region:United States
-
On CPHI since:2024
-
Certificates:4
-
Employees:1000 - 4999
Company types
Primary activities
Other Content from Simtra BioPharma Solutions (2)
-
Brochure Our Capabilities- Your Partner for Vital Injectable Products
With 65+ years focused exclusively on sterile injectables, Simtra BioPharma Solutions brings integrated scientific, technical and manufacturing expertise — from development through global commercial fill/finish. As an agile, independent contract development and manufacturing organization (CDMO), we partner with pharma and biotech companies to reduce risk, scale with confidence and accelerate delivery of high-quality injectables to patients. -
Brochure Connecting All Your Dots. Simtra's dedicated bioconjugation suite is coming soon.
Simtra BioPharma Solutions is extending its proven sterile injectable formulation and fill/finish expertise upstream into bioconjugation — creating a more integrated drug substance (DS) and drug product (DP) solution under one roof.
Designed to be platform-agnostic, Simtra enables customers to select the conjugation science that best fits their molecule, while benefiting from a single, integrated CDMO partner.
By reducing handoffs and simplifying development, Simtra helps accelerate the path from DS to DP — without the technical trade-offs.
Simtra's dedicated bioconjugation suite is coming soon.